Search

Author/Creator Chasalow, Scott D

1. Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. (4th November 2015)

Authors:
Sznol, Mario; Fishman, Mayer; Escudier, Bernard; McDermott, David F; Kluger, Harriet; Stadler, Walter M; Perez-Gracia, Jose; McNeel, Douglas G; Curti, Brendan D; Harrison, Michael R; Plimack, Elizabeth R; Appleman, Leonard; Fong, Lawrence; Drake, Charles G; Young, Tina C; Chasalow, Scott D; Ross-...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC. Issue 3 (3rd March 2021)

Authors:
Ross-Macdonald, Petra; Walsh, Alice M; Chasalow, Scott D; Ammar, Ron; Papillon-Cavanagh, Simon; Szabo, Peter M; Choueiri, Toni K; Sznol, Mario; Wind-Rotolo, Megan
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 3(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search